US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Zenas BioPharma Inc.

9.69

+0.11001.15%

Post-market: 9.690.00000.00%16:04 EDT

Volume:164.81K

Turnover:1.59M

Market Cap:405.37M

PE:-1.38

High:9.86

Open:9.61

Low:9.41

Close:9.58

Loading ...

Overview Company News Filings

Zenas BioPharma Inc. Grants Stock Options to New Employee Under Nasdaq Rule, Vesting Over Four Years

Zenas Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Zenas BioPharma Announces Board Changes at Annual Meeting

Zenas BioPharma to Present at Jefferies Conference

Zenas BioPharma Inc. to Present at Jefferies Global Healthcare Conference

Zenas BioPharma Reports Q1 2025 Financial Results

Zenas BioPharma Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Zenas BioPharma’s Promising Autoimmune Pipeline and Obexelimab’s Competitive Edge Drive Buy Rating

BRIEF-Zenas Biopharma Reports First Quarter 2025 Financial Results

Zenas BioPharma Q1 EPS $(0.80) Beats $(1.05) Estimate, Sales $10.00M Beat $1.67M Estimate

Zenas Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates

THOMSON REUTERS

Zenas BioPharma Insiders US$407k Short Of Breakeven On Stock Purchase

Simply Wall St.

Zenas BioPharma, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP Before June 16, 2025 to Discuss Your Rights – ZBIO

Zenas Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zenas BioPharma appoints Haley Laken as CSO

Zenas Biopharma Appoints Haley Laken, Ph.d., as Chief Scientific Officer

THOMSON REUTERS

Press Release: Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer

North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs

Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ZBIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ZBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","market":"US","secType":"STK","nameCN":"Zenas BioPharma Inc.","latestPrice":9.69,"timestamp":1751313600000,"preClose":9.58,"halted":0,"volume":164808,"hourTrading":{"tag":"盘后","latestPrice":9.69,"preClose":9.69,"latestTime":"16:04 EDT","volume":1925,"amount":18653.25,"timestamp":1751313854369},"delay":0,"floatShares":20950537,"shares":41834182,"eps":-6.997271,"marketStatus":"Post-Mkt","change":0.11,"latestTime":"06-30 16:54:53 EDT","open":9.61,"high":9.86,"low":9.41,"amount":1591608.8281,"amplitude":0.046973,"askPrice":10.44,"askSize":300,"bidPrice":8.7,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-6.997271,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1751328000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1726200000000,"exchange":"NASDAQ","adjPreClose":9.58,"sharesOutstanding":249967,"nav":10.0592,"aum":2514468.0464,"dividendRate":0.000103,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":9.99,"preClose":9.58,"latestTime":"09:19 EDT","volume":2,"amount":19.98,"timestamp":1751289587983},"postHourTrading":{"tag":"盘后","latestPrice":9.69,"preClose":9.69,"latestTime":"16:04 EDT","volume":1925,"amount":18653.25,"timestamp":1751313854369},"volumeRatio":0.785652},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ZBIO\",,,,,undefined,":{"symbol":"ZBIO","floatShares":20950537,"roa":"-56.70%","roe":"-115.47%","lyrEps":-11.893967,"volumeRatio":0.785652,"shares":41834182,"dividePrice":0.001,"high":9.86,"amplitude":0.046973,"preClose":9.58,"low":9.41,"week52Low":5.83,"pbRate":"1.43","psRate":"27.02","week52High":26.2508,"institutionHeld":0,"latestPrice":9.69,"committee":-0.846154,"eps":-6.997271,"divideRate":0.000103,"volume":164808,"delay":0,"ttmEps":-6.997271,"open":9.61,"prevYearClose":8.19,"prevWeekClose":9.58,"prevMonthClose":9.52,"prevQuarterClose":7.9,"fiveDayClose":9.47,"twentyDayClose":9.52,"sixtyDayClose":8.43},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ZBIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2545170294","title":"Zenas BioPharma Inc. Grants Stock Options to New Employee Under Nasdaq Rule, Vesting Over Four Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2545170294","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545170294?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:15","pubTimestamp":1750450510,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., June 20, 2025 - Zenas BioPharma Inc. , a global biopharmaceutical company focused on autoimmune disease therapies, has announced a new stock option grant for a newly hired employee. On June 16, 2025, the company's Compensation Committee approved a non-qualified stock option to purchase 112,000 shares of Zenas' common stock as an inducement material for the employee's entry into the company. The stock option, priced at $9.97 per share, the closing price on the grant date, has a ten-year term. Vesting of the stock options will occur over four years, with 25% vesting on the first anniversary of employment and the remainder vesting in 36 equal monthly installments, contingent on continued employment with Zenas. This grant aligns with Nasdaq Listing Rule 5635 and is governed by an Inducement Option Award Agreement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL9GxK0X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2210149790.SGD","LU2095319765.USD","BK4585","IE00BKPKM429.USD","BK4588","NDAQ","BK4139","ZBIO","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112"],"gpt_icon":0},{"id":"2545704091","title":"Zenas Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2545704091","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545704091?lang=en_us&edition=fundamental","pubTime":"2025-06-21 04:15","pubTimestamp":1750450500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nTUAYSFF4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2543554096","title":"Zenas BioPharma Announces Board Changes at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2543554096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543554096?lang=en_us&edition=fundamental","pubTime":"2025-06-13 05:07","pubTimestamp":1749762431,"startTime":"0","endTime":"0","summary":"Zenas BioPharma, Inc. ( ($ZBIO) ) has provided an announcement. On June 10, 2025, Zenas BioPharma, Inc. held its 2025 Annual Meeting of Stockholder...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zenas-biopharma-announces-board-changes-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zenas-biopharma-announces-board-changes-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2540068571","title":"Zenas BioPharma to Present at Jefferies Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068571","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540068571?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:19","pubTimestamp":1749035964,"startTime":"0","endTime":"0","summary":"Zenas BioPharma, Inc. ( ($ZBIO) ) just unveiled an announcement. Zenas BioPharma announced its participation in the Jefferies Global Healthcare Con...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zenas-biopharma-to-present-at-jefferies-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zenas-biopharma-to-present-at-jefferies-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2539254796","title":"Zenas BioPharma Inc. to Present at Jefferies Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2539254796","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539254796?lang=en_us&edition=fundamental","pubTime":"2025-05-29 19:05","pubTimestamp":1748516709,"startTime":"0","endTime":"0","summary":"Zenas BioPharma Inc., a clinical-stage global biopharmaceutical company focused on therapies for autoimmune diseases, is set to present at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 1:25 p.m. ET. A live webcast and archived replay of the presentation will be available on the company's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zenas Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire  on May 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL1lYSH2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00BGHQF748.EUR","LU2095319765.USD","IE00BKPKM429.USD","BK4588","IE00B3QW5Z07.USD","NDAQ","LU2210149790.SGD","LU2210150020.SGD","ZBIO","IE00B64PRP62.GBP","BK4585","BK4139"],"gpt_icon":0},{"id":"2536725923","title":"Zenas BioPharma Reports Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2536725923","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536725923?lang=en_us&edition=fundamental","pubTime":"2025-05-17 11:59","pubTimestamp":1747454362,"startTime":"0","endTime":"0","summary":"Zenas BioPharma, Inc. ( ($ZBIO) ) has released its Q1 earnings. Here is a breakdown of the information Zenas BioPharma, Inc. presented to its inves...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zenas-biopharma-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zenas-biopharma-reports-q1-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2535139501","title":"Zenas BioPharma Price Target Maintained With a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2535139501","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535139501?lang=en_us&edition=fundamental","pubTime":"2025-05-16 19:17","pubTimestamp":1747394220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 16, 2025 07:17 ET (11:17 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO"],"gpt_icon":0},{"id":"2535603533","title":"Zenas BioPharma’s Promising Autoimmune Pipeline and Obexelimab’s Competitive Edge Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535603533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535603533?lang=en_us&edition=fundamental","pubTime":"2025-05-16 18:17","pubTimestamp":1747390661,"startTime":"0","endTime":"0","summary":"Analyst Matthew Caufield from H.C. Wainwright reiterated a Buy rating on Zenas BioPharma, Inc. (ZBIO – Research Report) and keeping the price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/zenas-biopharmas-promising-autoimmune-pipeline-and-obexelimabs-competitive-edge-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/zenas-biopharmas-promising-autoimmune-pipeline-and-obexelimabs-competitive-edge-drive-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBIO"],"gpt_icon":0},{"id":"2535841300","title":"BRIEF-Zenas Biopharma Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2535841300","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535841300?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:37","pubTimestamp":1747309057,"startTime":"0","endTime":"0","summary":"BRIEF-Zenas Biopharma Reports First Quarter 2025 Financial Results May 15 (Reuters) - Zenas Biopharma Inc ZBIO.O:ZENAS BIOPHARMA REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA9W8LV2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ZBIO"],"gpt_icon":0},{"id":"2535846178","title":"Zenas BioPharma Q1 EPS $(0.80) Beats $(1.05) Estimate, Sales $10.00M Beat $1.67M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535846178","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535846178?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:15","pubTimestamp":1747307730,"startTime":"0","endTime":"0","summary":"Zenas BioPharma (NASDAQ:ZBIO) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.05) by 23.81 percent. This is a 95.53 percent increase over losses of $(17.89) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45432726/zenas-biopharma-q1-eps-0-80-beats-1-05-estimate-sales-10-00m-beat-1-67m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO"],"gpt_icon":0},{"id":"2535845432","title":"Zenas Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2535845432","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535845432?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:05","pubTimestamp":1747307100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA9W8LV2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2529500758","title":"Zenas BioPharma Insiders US$407k Short Of Breakeven On Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2529500758","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529500758?lang=en_us&edition=fundamental","pubTime":"2025-04-23 20:27","pubTimestamp":1745411261,"startTime":"0","endTime":"0","summary":"Insiders who bought US$2.11m worth of Zenas BioPharma, Inc.  stock in the last year have seen some of their losses recouped as the stock gained 12% last week. However, the purchase is proving to be a costly gamble, since losses made by insiders have totalled US$407k since the time of purchase.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.  Our free stock report includes 3 warning signs investors should be aware of before investing in Zenas BioPharma.Zenas BioPharma Insider Transactions Over The Last Year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zenas-biopharma-insiders-us-407k-122741518.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2528779147","title":"Zenas BioPharma, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky LLP Before June 16, 2025 to Discuss Your Rights – ZBIO","url":"https://stock-news.laohu8.com/highlight/detail?id=2528779147","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528779147?lang=en_us&edition=fundamental","pubTime":"2025-04-18 05:05","pubTimestamp":1744923903,"startTime":"0","endTime":"0","summary":"THE LAWSUIT: This lawsuit is on behalf of persons who purchased or otherwise acquired Zenas BioPharma securities pursuant and/or traceable to the r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/zenas-biopharma-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-llp-before-june-16-2025-to-discuss-your-rights-zbio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/zenas-biopharma-inc-sued-for-securities-law-violations-investors-should-contact-levi-korsinsky-llp-before-june-16-2025-to-discuss-your-rights-zbio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","ZBIO","BK4139","BK4211"],"gpt_icon":0},{"id":"2528713773","title":"Zenas Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528713773","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528713773?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:20","pubTimestamp":1744921232,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA1TY5YB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZBIO"],"gpt_icon":0},{"id":"2528084774","title":"Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2528084774","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528084774?lang=en_us&edition=fundamental","pubTime":"2025-04-18 04:20","pubTimestamp":1744921200,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., April 17, 2025  -- Zenas BioPharma, Inc.  , a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced that on April 15, 2025 , the Compensation Committee of the Company’s Board of Directors  granted non-qualified stock options to two newly hired officers of the Company, each as an inducement material to each officer’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635.The Committee granted a non-qualified stock option to purchase 400,000 shares of the Company’s common stock to Lisa von Moltke, M.D., who was recently appointed to the role of Head of Research and Development and Chief Medical Officer . In addition, the Committee granted a non-qualified stock option to purchase 250,000 shares of the Company’s common stock to Haley Laken, Ph.D., the Company’s new Chief Scientific Officer .The Zenas BioPharma word mark, logo mark","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zenas-biopharma-announces-inducement-grants-202000706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU2095319765.USD","USJW.SI","MNQmain","TSYW.SI","PSQ","ZBIO","IE00BGHQF748.EUR","NDAQ","USAW.SI","SQQQ","TQQQ","BK4112","NQmain",".IXIC","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","QID","BK4588","QLD","IE00BKPKM429.USD","LU2210149790.SGD","NVIW.SI","IE00B64PRP62.GBP"],"gpt_icon":1},{"id":"2525148720","title":"Zenas BioPharma appoints Haley Laken as CSO","url":"https://stock-news.laohu8.com/highlight/detail?id=2525148720","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525148720?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:15","pubTimestamp":1744024523,"startTime":"0","endTime":"0","summary":"Zenas BioPharma (ZBIO) announced the appointment of Haley Laken, Ph.D., as Chief Scientific Officer. Prior to joining Zenas, Dr. Laken served as CO...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-appoints-haley-laken-as-cso?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/zenas-biopharma-appoints-haley-laken-as-cso?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ZBIO"],"gpt_icon":0},{"id":"2525197040","title":"Zenas Biopharma Appoints Haley Laken, Ph.d., as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525197040","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525197040?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:05","pubTimestamp":1744023900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250407:nTUAB23FCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ZBIO"],"gpt_icon":0},{"id":"2525019072","title":"Press Release: Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2525019072","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525019072?lang=en_us&edition=fundamental","pubTime":"2025-04-07 19:05","pubTimestamp":1744023900,"startTime":"0","endTime":"0","summary":"Dr. Laken brings over 25 years of leadership experience in research, development operations, scientific assessment and strategy. WALTHAM, Mass., April 07, 2025  -- Zenas BioPharma, Inc.  , a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced the appointment of Haley Laken, Ph.D., as Chief Scientific Officer . Dr. Laken brings significant scientific insight and leadership experience in research, development operations, R&D strategy and business development.Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candida","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZBIO","BK4139"],"gpt_icon":0},{"id":"2521037934","title":"North American Morning Briefing: Stock Futures Fall as Focus Shifts From Fed to Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2521037934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521037934?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:02","pubTimestamp":1742551320,"startTime":"0","endTime":"0","summary":"The euphoria from the Federal Reserve's policy meeting didn't last long.Stock futures were lower Friday as attention shifted from the Fed to the prospect of further tariffs.Trump said in a social media post that the planned imposition of reciprocal tariffs on April 2 would be \"Liberation Day\" in the U.S.\"We maintain our view that the FOMC outcome was effectively a one-day move, with minimal legacy in terms of immediate direction. That said, we also view the FOMC outcome as a whole as nodding towards dovishness, but with numerous caveats,\" ING said.Quantum-computing stocks  are likely to be in focus after suffering steep falls on Thursday as investors appeared unimpressed by their contributions to Nvidia's Quantum Day at its GTC developers' event.The market also faces a test as an estimated $4.5 trillion in options contracts expire, which could increase volatility.FedEx fell 5.1% off hours after it cut its outlook for the year.Lennar management warned investors of a weak housing market.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXYN","NVDX","PURE","XOMA","GORV","NVDY","NVDS","US12M.BOND","US10Y.BOND","ADVM","NVDS.UK","PRPH","NGNE","US7Y.BOND","USAU","US3Y.BOND","NVDA","MPU","US30Y.BOND","2NVD.UK","US2Y.BOND","ZBIO","AFG","OLMA","SGMA","BOLD","CKPT","NVDU","FBRX","CCL","US6M.BOND","FBLG","NVDL","IMRX","JVA","ET","US5Y.BOND","IRD","NVD2.UK","IMNM","ATXI","NVD3.UK","BPTH","DM","SNVD.UK","NVDD","NVIW.SI","3NVD.UK","SMXT"],"gpt_icon":1},{"id":"2521849599","title":"Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2521849599","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521849599?lang=en_us&edition=fundamental","pubTime":"2025-03-21 02:54","pubTimestamp":1742496883,"startTime":"0","endTime":"0","summary":"On Thursday, Wedbush initiated coverage on Zenas BioPharma, Inc. , a clinical-stage global biopharmaceutical company focused on developing therapies for autoimmune disease.Zenas BioPharma started trading on the NASDAQ in September 2024. The company closed an upsized initial public offering of 15.22 million shares at $17 per share, raising approximately $258.7 million in gross proceeds.The company’s lead program obexelimab concluded enrollment in the Phase 3 INDIGO trial for immunoglobulin-G4-Related Disease . Topline data is expected by the end of 2025.The company also initiated the Phase 2 MoonStone trial for Relapsing Multiple Sclerosis  and the Phase 2 SunStone trial for Systemic Lupus Erythematosus .Wedbush initiated coverage with an outperform rating and a price forecast of $35.Analyst Fan writes that the unique safety feature is especially important for conditions like IgG4-RD, MS, and SLE, where long-term safety and immune protection influence treatment decisions.This article Ze","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zenas-biopharma-gains-outperform-rating-185443725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRGS","ZBIO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ZBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"ZBIO","fiscalQuarterEnding":"2025/03","expectedEps":-1.15,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.8},{"market":"US","date":"2024-11-12","symbol":"ZBIO","fiscalQuarterEnding":"2024/09","expectedEps":13,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-5.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ZBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ZBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.7143,"buy":0.2857,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.7143,"analysts":7,"updateTime":1742529600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ZBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ZBIO","date":"2025-06-27","current":-2.608837,"percent":0.571429,"low":-19.592941,"twenty":-12.215932,"median":-2.714219,"eighty":-2.322158,"high":-1.802568,"avg":-5.301613,"sd":4.974644,"marketCap":424616947},"quantilePoints":[{"date":"2024-09-13","current":-8.364044,"twenty":-11.189626,"median":-10.130033,"eighty":-9.07044,"marketCap":457989962},{"date":"2024-09-20","current":-12.731934,"twenty":-12.968841,"median":-12.731934,"eighty":-9.523082,"marketCap":697162515},{"date":"2024-09-27","current":-12.564791,"twenty":-13.484804,"median":-12.909978,"eighty":-12.029776,"marketCap":688010267},{"date":"2024-10-04","current":-14.275075,"twenty":-13.747873,"median":-12.811872,"eighty":-12.31335,"marketCap":781660299},{"date":"2024-10-11","current":-13.008553,"twenty":-13.941177,"median":-13.027627,"eighty":-12.397648,"marketCap":712309358},{"date":"2024-10-18","current":-16.373229,"twenty":-14.273549,"median":-13.29848,"eighty":-12.477586,"marketCap":896548905},{"date":"2024-10-25","current":-17.845752,"twenty":-15.022781,"median":-13.503182,"eighty":-12.59822,"marketCap":977179818},{"date":"2024-10-31","current":-16.022265,"twenty":-16.022265,"median":-13.891034,"eighty":-12.731934,"marketCap":877331175},{"date":"2024-11-08","current":-15.961228,"twenty":-15.961228,"median":-14.267446,"eighty":-12.811872,"marketCap":873988961},{"date":"2024-11-15","current":-6.06727,"twenty":-16.022265,"median":-14.202594,"eighty":-12.564791,"marketCap":782495852},{"date":"2024-11-22","current":-3.382919,"twenty":-15.961228,"median":-13.807463,"eighty":-11.896022,"marketCap":436298426},{"date":"2024-11-29","current":-3.729636,"twenty":-15.955124,"median":-13.496851,"eighty":-6.578437,"marketCap":481014835},{"date":"2024-12-06","current":-3.402361,"twenty":-15.898664,"median":-13.178717,"eighty":-4.851473,"marketCap":438805888},{"date":"2024-12-13","current":-2.997318,"twenty":-15.744546,"median":-13.008553,"eighty":-3.729636,"marketCap":386567092},{"date":"2024-12-20","current":-3.162575,"twenty":-15.636205,"median":-12.771903,"eighty":-3.606503,"marketCap":407880521},{"date":"2024-12-27","current":-3.256545,"twenty":-15.585849,"median":-12.510288,"eighty":-3.394584,"marketCap":419999921},{"date":"2025-01-03","current":-2.91955,"twenty":-15.427152,"median":-12.339512,"eighty":-3.24488,"marketCap":376537243},{"date":"2025-01-10","current":-3.007039,"twenty":-15.189107,"median":-10.412935,"eighty":-3.188498,"marketCap":387820823},{"date":"2025-01-17","current":-2.520987,"twenty":-15.022781,"median":-6.676265,"eighty":-3.159983,"marketCap":325134267},{"date":"2025-01-24","current":-2.715408,"twenty":-14.870188,"median":-6.06727,"eighty":-3.071846,"marketCap":350208890},{"date":"2025-01-31","current":-2.469142,"twenty":-14.351372,"median":-4.794107,"eighty":-2.968155,"marketCap":318447701},{"date":"2025-02-07","current":-2.54367,"twenty":-14.313224,"median":-3.888412,"eighty":-2.841781,"marketCap":328059640},{"date":"2025-02-14","current":-2.313605,"twenty":-14.275075,"median":-3.716674,"eighty":-2.653842,"marketCap":298388004},{"date":"2025-02-21","current":-2.530708,"twenty":-14.268972,"median":-3.643766,"eighty":-2.622086,"marketCap":326387998},{"date":"2025-02-28","current":-2.141867,"twenty":-14.163683,"median":-3.476889,"eighty":-2.54367,"marketCap":276238754},{"date":"2025-03-07","current":-2.35573,"twenty":-14.007233,"median":-3.332693,"eighty":-2.517747,"marketCap":303820838},{"date":"2025-03-14","current":-2.324434,"twenty":-13.840892,"median":-3.246824,"eighty":-2.465902,"marketCap":364908203},{"date":"2025-03-21","current":-2.26852,"twenty":-13.569102,"median":-3.188498,"eighty":-2.360915,"marketCap":356130342},{"date":"2025-03-28","current":-2.138053,"twenty":-13.499383,"median":-3.165816,"eighty":-2.351842,"marketCap":335648668},{"date":"2025-04-04","current":-2.076814,"twenty":-13.408148,"median":-3.159335,"eighty":-2.284767,"marketCap":326034820},{"date":"2025-04-11","current":-1.80523,"twenty":-13.315978,"median":-3.071846,"eighty":-2.26652,"marketCap":283399498},{"date":"2025-04-17","current":-2.21793,"twenty":-13.154764,"median":-2.997318,"eighty":-2.257224,"marketCap":348188468},{"date":"2025-04-25","current":-2.657256,"twenty":-13.051602,"median":-2.943853,"eighty":-2.261324,"marketCap":417157373},{"date":"2025-05-02","current":-3.077944,"twenty":-13.023813,"median":-2.968155,"eighty":-2.26639,"marketCap":483200324},{"date":"2025-05-09","current":-2.4756,"twenty":-13.008271,"median":-2.943853,"eighty":-2.269325,"marketCap":388639550},{"date":"2025-05-16","current":-2.503456,"twenty":-12.890356,"median":-2.890387,"eighty":-2.270833,"marketCap":407464932},{"date":"2025-05-23","current":-2.942974,"twenty":-12.763909,"median":-2.866084,"eighty":-2.272453,"marketCap":479001383},{"date":"2025-05-30","current":-2.570283,"twenty":-12.665077,"median":-2.835832,"eighty":-2.278934,"marketCap":418341820},{"date":"2025-06-06","current":-2.470042,"twenty":-12.521189,"median":-2.721889,"eighty":-2.297829,"marketCap":402026489},{"date":"2025-06-13","current":-2.90956,"twenty":-12.426717,"median":-2.835832,"eighty":-2.31327,"marketCap":473562940},{"date":"2025-06-20","current":-2.392933,"twenty":-12.365673,"median":-2.76689,"eighty":-2.315238,"marketCap":389476234},{"date":"2025-06-27","current":-2.608837,"twenty":-12.215932,"median":-2.714219,"eighty":-2.322158,"marketCap":424616947}],"updateTime":1751295087078}}}